Literature DB >> 32100381

Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR.

Ping Yang1, Han Zeng1, Wei Tan1, Xiaoqing Luo1, Enze Zheng1, Lei Zhao1, Li Wei1, Xiong Z Ruan1,2,3, Yao Chen4, Yaxi Chen1.   

Abstract

A contradictory role of CD36 in insulin resistance was found to be related to the nutrient state. Here, we examined that the physiological functions of CD36 in insulin signal transduction in mice fed a low-fat diet. CD36 deficiency led to hepatic insulin resistance and decreased insulin-stimulated tyrosine phosphorylation of insulin receptor β (IRβ) in mice fed a low-fat diet. The ability of insulin to bind with IR did not differ between WT and CD36-deficient hepatocytes. CD36 formed a complex with IRβ and dissociation of CD36/Fyn complex or inhibition of Fyn only partially reversed the effects of CD36 on hepatic insulin signaling. Furthermore, we found that CD36 deficiency led to abnormally increased hepatic protein-tyrosine phosphatase 1B (PTP1B) expression and enhanced PTP1B and IR interactions, which contributed to the decreased insulin signaling and disordered glucose metabolism. In addition, increased endoplasmic reticulum (ER) stress was found in the livers of the CD36-deficient mice, while inhibited ER stress normalized the PTP1B expression and restored insulin signaling in the CD36-deficient mice. Our findings suggest that the loss of CD36 impairs hepatic insulin signaling by enhancing the PTP1B/IR interaction that is induced by ER stress, indicating a possible critical step in the progression of hepatic insulin resistance.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  CD36; ER stress; IR; PTP1B; insulin sensitivity

Year:  2020        PMID: 32100381     DOI: 10.1096/fj.201902777RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption.

Authors:  Lide Tao; Xiangmin Ding; Lele Yan; Guangcai Xu; Peijian Zhang; Anlai Ji; Lihong Zhang
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

2.  [CD36 gene deletion reduces muscle insulin sensitivity in mice by up-regulating PTP1B expression].

Authors:  L Chen; H Zeng; H Qin; X Ruan; P Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-03-20

Review 3.  Thrombospondin 1 in Metabolic Diseases.

Authors:  Linda S Gutierrez; Jovita Gutierrez
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-29       Impact factor: 5.555

4.  The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis.

Authors:  Xiaoqing Luo; Enze Zheng; Li Wei; Han Zeng; Hong Qin; Xiaoyu Zhang; Meng Liao; Lin Chen; Lei Zhao; Xiong Z Ruan; Ping Yang; Yaxi Chen
Journal:  Cell Death Dis       Date:  2021-03-26       Impact factor: 8.469

5.  CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis.

Authors:  Ping Yang; Hong Qin; Yiyu Li; Anhua Xiao; Enze Zheng; Han Zeng; Chunxiao Su; Xiaoqing Luo; Qiannan Lu; Meng Liao; Lei Zhao; Li Wei; Zac Varghese; John F Moorhead; Yaxi Chen; Xiong Z Ruan
Journal:  Nat Commun       Date:  2022-10-02       Impact factor: 17.694

6.  An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy.

Authors:  Zhenyu Bai; Ting Xie; Tianhao Liu; Zedong Chen; Linde Yu; Chao Zhang; Jincheng Luo; Liguo Chen; Xiaoshan Zhao; Ya Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.